Karyopharm Therapeutics reported $-41269000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Abbott ABT:US $ 3899M 1051M
Abbvie ABBV:US $ 6567M 197M
Amgen AMGN:US $ 2727M 56M
Astrazeneca AZN:US $ 3709M 624M
Biocryst Pharmaceuticals BCRX:US $ -73.92M 58.39M
Bristol Myers Squibb BMY:US $ 5386M 595M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.44M
Epizyme EPZM:US $ -55.47M 4.84M
Johnson & Johnson JNJ:US $ 8218M 1879M
Karyopharm Therapeutics KPTI:US $ -41269000 79.87M
Macrogenics MGNX:US $ -66.44M 8.42M
Merk MRK:US $ 6309M 1525M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Novartis NOVN:VX SF 3912M 230M
Novartis NVS:US $ 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Sangamo Biosciences SGMO:US $ -43.92M 6.36M
Takeda 4502:JP Y -54047M 126240M
Tg Therapeutics TGTX:US $ -69.01M 24.32M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
Xencor XNCR:US $ 23.59M 49.47M
YTE INCY:US $ 172.84M 1.75M